Consolidated Statement of Stockholders' Equity (unaudited) - USD ($)	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit	Non-controlling Interest
Beginning Balance, Amount at Sep. 30, 2018	$ 95,241,001	$ 180,875	$ 582,902,694	$ (21,564)	$ (487,265,816)	$ (555,188)
Beginning Balance, Shares at Sep. 30, 2018		88,505,302
Stock-based compensation	2,717,534		2,717,534
Exercise of stock options, Amount	1,004,694	$ 166	1,004,528
Exercise of stock options, Shares		166,327
Common stock - restricted stock units vesting, Amount		$ 659	(659)
Common stock - restricted stock units vesting, Shares		658,959
Common stock - issued for cash, Amount	60,521,729	$ 3,261	60,518,468
Common stock - issued for cash, Shares		3,260,869
Foreign currency translation adjustments	(22,180)			(22,180)
Net income (loss)	12,037,253				12,037,253
Ending Balance, Amount at Dec. 31, 2018	171,500,031	$ 184,961	647,142,565	(43,744)	(475,228,563)	(555,188)
Ending Balance, Shares at Dec. 31, 2018		92,591,457
Beginning Balance, Amount at Sep. 30, 2019	244,036,252	$ 187,876	664,086,155	(391,624)	(419,290,967)	(555,188)
Beginning Balance, Shares at Sep. 30, 2019		95,506,271
Stock-based compensation	4,491,752		4,491,752
Exercise of stock options, Amount	$ 3,001,554	$ 472	3,001,082
Exercise of stock options, Shares	472,193	472,193
Common stock - restricted stock units vesting, Amount		$ 533	(533)
Common stock - restricted stock units vesting, Shares		533,333
Common stock - issued for cash, Amount	$ 250,476,739	$ 4,600	250,472,139
Common stock - issued for cash, Shares		4,600,000
Foreign currency translation adjustments	196,074			196,074
Net income (loss)	(2,673,728)				(2,673,728)
Ending Balance, Amount at Dec. 31, 2019	$ 499,528,643	$ 193,481	$ 922,050,595	$ (195,550)	$ (421,964,695)	$ (555,188)
Ending Balance, Shares at Dec. 31, 2019		101,111,797